Follow The Filings

PACB position history

The shares of Pacific Biosciences Calif (PACB) that ARK Investment Management LLC reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2021 Q3: 22,723,075 shares, $581M, 1.4% of portfolio
  2. 2021 Q4: 26,383,103 shares, $540M, 1.6% of portfolio, Add +16.1%
  3. 2022 Q1: 27,259,521 shares, $248M, 1.0% of portfolio, Add +3.3%
  4. 2022 Q2: 28,045,530 shares, $158M, 0.93% of portfolio, Add +2.9%
  5. 2022 Q3: 28,692,494 shares, $167M, 1.2% of portfolio, Add +2.3%
  6. 2022 Q4: 25,691,681 shares, $210M, 1.8% of portfolio, Reduce −10.5%
  7. 2023 Q1: 27,753,679 shares, $321M, 2.2% of portfolio, Add +8.0%
  8. 2023 Q2: 26,634,620 shares, $354M, 2.3% of portfolio, Reduce −4.0%
  9. 2023 Q3: 29,822,440 shares, $249M, 1.9% of portfolio, Add +12.0%
  10. 2023 Q4: 34,504,273 shares, $338M, 2.0% of portfolio, Add +15.7%
  11. 2024 Q1: 33,290,137 shares, $125M, 0.86% of portfolio, Reduce −3.5%
  12. 2024 Q2: 33,212,454 shares, $46M, 0.40% of portfolio, Reduce −0.2%
  13. 2024 Q3: 33,406,401 shares, $57M, 0.52% of portfolio, Add +0.6%
  14. 2024 Q4: 36,044,362 shares, $66M, 0.55% of portfolio, Add +7.9%
  15. 2025 Q1: 36,478,441 shares, $43M, 0.43% of portfolio, Add +1.2%
  16. 2025 Q2: 36,298,163 shares, $45M, 0.33% of portfolio, Reduce −0.5%
  17. 2025 Q3: 30,924,103 shares, $40M, 0.24% of portfolio, Reduce −14.8%
  18. 2025 Q4: 37,264,228 shares, $70M, 0.46% of portfolio, Add +20.5%
  19. 2026 Q1: 36,273,288 shares, $48M, 0.37% of portfolio, Reduce −2.7%
  20. 2026 Q2: 29,781,416 shares, $50M, 0.32% of portfolio, Reduce −17.9%
  21. 2026 Q3: 29,749,893 shares, $71M, 0.41% of portfolio, Reduce −0.1%
Holdings date Value % of holdings Shares Filing date All 13F holders